BLRX vs CANF: Side-by-Side Comparison
Compare Bioline Rx Ltd (BLRX) and Can-Fite Biopharma Ltd (CANF) side by side: market cap USD 14.29M vs USD 5.12M. Financials, growth and model signals on Bullrun.
| Metric | BLRX | CANF |
|---|---|---|
| Company | Bioline Rx Ltd | Can-Fite Biopharma Ltd |
| Country / Exchange | Israel · NASDAQ | Israel · NYSE MKT |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 14.29M | USD 5.12M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | — | USD 405.00K |
| Revenue growth YoY | — | -39.9% |
| Net income | — | USD -9.83M |
| Gross margin | — | — |
| Diluted EPS | — | -5.97 |